Table 3.
Representative examples of therapeutic monoclonal antibodies
| Molecule | Name | Type | Disease target |
|---|---|---|---|
| TNF | Infliximab | Chimera | RA, Crohn’s diseases, Behçet’s disease |
| Adalimumab | Human | ||
| Golimumab | Human | ||
| Etanercept | TNFR-Ig | ||
| Certolizumab pegol | Fab-pegosyl | ||
| CD20 | Rituximab | Chimera | B-cell lymphoma (vasculitis) |
| Ocrelizumab | Humanized | ||
| Ofatumumab | Human | ||
| IL6R | Tocilizumab | Humanized | RA |
| Sarilumab | Human | ||
| CTLA4 | Abatacept | CTLA4-Ig | RA |
| IL17 | Secukinumab | Human | Psoriasis |
| Ixekizumab | Humanized | ||
| Brodalumab | Human | ||
| CD52 | Alemtuzumab | Humanized | Multiple sclerosis |
| IgE | Omalizumab | Humanized | Severe asthma, chronic urticaria |
CTLA, cytotoxic T-lymphocyte-associated protein.